Positioning no disclosures inside 60 days, left as found
Options put/call open interest 11.96, read 2026-11-05
Ethical does not pass the values gate
Price1.79 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Markdown1.80-0.6% to today ✓Distribution gives way to Markdown after an 11% slide in 7 days
2026-10-25Read Distribution2.02-11.4% to today ✓Markdown gives way to Distribution after a 55% slide in 16 weeks
2026-07-02Read Markdown4.44-59.7% to today ✓First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Opendoor Technologies Inc. holds its Distribution at $1.79. Elevated stress, defensive posture warranted, held for 155 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 155 days
Price at the screen
$1.79
Valuation
N/A trailing · -23.61 forward price to earnings
Values screen
FAIL· score 70.0
Beta
3.78
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
54.84%
Below 33%
Interest-bearing debt is 54.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
39.97%
Below 49%
Money owed to the company is 40.0% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Opendoor Technologies's business is in a permissible area, but its interest-bearing debt is about 55% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when OPEN's ethical verdict changes
Today OPEN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 2.37x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Online home flipper bleeding cash in a downturn
Picture someone trying to run an online house flipping business when buyers vanish and prices swing. Opendoor does exactly that through its digital platform yet the numbers show no path to steady profits. With an opportunity rating of none we pass despite the modest gap to our fair value estimate.
Revenue fell 38 percent while the forward earnings multiple sits at a negative 380 times and profit margins remain at minus 35 percent. Return on equity of minus 174 percent underlines how much capital is being destroyed. The ethical screen clears but that alone does not fix a business model tied to volatile housing transactions.
Real estate cycles can turn quickly and this company has yet to prove it can survive the next downturn without further dilution or losses. Analyst targets cluster around the current price yet offer little margin for error. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OPEN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markdown$1.98+13.8%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 13.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Markdown$1.74-3.3%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markdown$1.80+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$1.80+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown · changed$1.80-9.1%Entry 13
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Distribution$1.98+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Distribution$1.98+0.0%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Distribution$1.98-2.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution · changed$2.02+1.5%Entry 9
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter.
2026-10-18Markdown$1.99-12.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 672%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net buyers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
